Schedule 13G ownership disclosure

BioLineRx Ltd.

Security class unavailable · CUSIP: 09071M106

Event date: 2014-12-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
50,000,000
Percent of class
12.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-14-088001
Form type
SC 13G
Filer
BioLineRx Ltd.
CIK
CIK 1498403
Filed
Dec 22, 2014
Reporting period
Dec 16, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub